The Conference opened with a plenary session under the motto “Strong Regulator – Strong Industry” moderated by Dmitry Galkin, Director of the Department of Development of Pharmaceutical and Medical Industry…

The Ultrix Quadri vaccine produced by the Nacimbio Holding of Rostec State Corporation has been approved by the Russian Ministry of Health for the vaccination of people over 60 years…

One of the most-attended sessions at GMP Conference 2019 was “The Certification of Conformity to GMP in the Context of Transition Towards a Common Market”.  

Roche has been a strategic partner of the All-Russia GMP Conference for several years and will be supporting the event in 2021. Roche’s experience and expertise in science advancement in…

Petrovax will act as a partner in a panel discussion dedicated to regulating the circulation of medicinal products within the EAEU, to be held as part of the 6th All-Russian…

Nacimbio is the General Partner of the VI All-Russian GMP Conference with International Participation The Nacimbio Holding Company of the Rostec State Corporation encompasses biopharmaceutical enterprises specialising in development, production, and marketing of…

The “Best Technical Director” competition is held within the framework of the VI All-Russian GMP Conference with International Participation, which will take place on September 22-24, 2021 in a hybrid…

The VI All-Russian GMP Conference with International Participation to be held on September 22-24, 2021 in a hybrid format will become one of the key events of the year in…

Gedeon Richter, a partner of the VI All-Russian GMP Conference with International Participation, is present in more than 100 countries around the world and has unique expertise in the implementation…

MSD, a partner of the VI All-Russian GMP Conference with International Participation, has been one of the leading international companies in the healthcare sector for over 125 years.  Its focuses…